The effects of a pre-season treatment with effective antimalarials on subsequent malaria morbidity in under five-year-old children living in high and seasonal malaria transmission area of Burkina Faso

Tropical Medicine and International Health

Volumn 15, Issue 11, 2010, Pages 1315-1321

  Ouédraogo, Alphonse ^a   Tiono, Alfred B ^a   Diarra, Amidou ^a   Nébié, Issa O ^a   Konaté, Amadou T ^a   Sirima, Sodiomon B ^a,b  

^a MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^b Groupe de Recherche Action en Sante   (Burkina Faso)

Author keywords

Malaria; Pre season; Single treatment

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIMALARIAL AGENT; BLOOD; CHILD HEALTH; COHORT ANALYSIS; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE TRANSMISSION; DISEASE TREATMENT; MALARIA; MORBIDITY; PARASITE; SEASONALITY;

ARTICLE; BLOOD SMEAR; BURKINA FASO; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFECT; FEMALE; FEVER; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MORBIDITY; PARASITEMIA; PREMEDICATION; PRESCHOOL CHILD; PROFESSIONAL PRACTICE; REINFECTION; SINGLE DRUG DOSE;

AGE DISTRIBUTION; ANTIMALARIALS; ARTEMISININS; BURKINA FASO; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; EPIDEMIOLOGIC METHODS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PYRIMETHAMINE; RECURRENCE; SEASONS; SEX DISTRIBUTION; SULFADOXINE; TREATMENT OUTCOME;

BURKINA FASO;

EID: 79251512975     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02618.x     Document Type: Article

References (29)

1. Abdulla S, Oberholzer R, Juma O et al. (2008) Safety and immunogenicity of RTS, S/AS02D malaria vaccine in infants. New England Journal of Medicine, 359, 2533-2544.
2. Barnes KI, Durrheim DN, Little F et al. (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Medicine, 2, 1123-1134.
3. Bejon P, Lusingu J, Olotu A et al. (2008) Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17months of age. New England Journal of Medicine, 359, 2521-2532.
4. Cisse B, Sokhna C, Boulanger D et al. (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet, 367, 659-667.
5. Coulibaly DAD, Thera MA, Dicko A et al. (2002) Impact of preseason treatment on incidence of Falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. American Journal of Tropical Medicine and Hygiene, 67(6), 604-610.
6. Coulibaly SO, Nezien D, Traore S & Kone B (2006) Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. Malaria Journal, 5(1), 49.
7. Desowitz RS, Elm J & Alpers MP (1993) Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from east Sepik Province, Papua New Guinea. Infection and Immunity, 61, 988-993.
8. Diourte Y, Djimde A, Doumbo OK et al. (1999) Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. American Journal of Tropical Medicine and Hygiene, 60, 475-478.
9. Färnert A, Rooth I, Svensson A, Snounou G & Björkman A (1999) Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. Journal of Infectious Diseases, 179, 989-995.
10. Franks S, Koram KA, Wagner GE et al. (2001) Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. Journal of Infectious Diseases, 183, 796-804.
11. Gansané A, Nébié I, Soulama I et al. (2009) Les raisons d'un changement de médicaments de première intention pour le traitement du paludisme simple au Burkina Faso en 2005. Bulletin de la Societe de Pathologie Exotique, 102, 31-35.
12. Goodman CA, Coleman PG & Mills AJ (2001) The cost-effectiveness of antenatal malaria prevention in sub-Saharan Africa. American Journal of Tropical Medicine and Hygiene, 64, 45-56.
13. Greenwood B (2004) The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. American Journal of Tropical Medicine and Hygiene, 70, 1-7.
14. Greenwood B (2008) Can malaria be eliminated? Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, 643-644.
15. Greenwood BM, Fidock DA, Kyle DE et al. (2008) Malaria: progress, perils, and prospects for eradication. Journal of Clinical Investigation, 118, 1266-1276.
16. Kayentao K, Kodio M, Newman RD et al. (2005) Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. Journal of Infectious Diseases 191, 109-116.
17. Kun JF, Missinou MA, Lell B et al. (2002) New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. American Journal of Tropical Medicine and Hygiene, 6, 653-658.
18. McGregor IA (1964) The passive transfer of human malaria immunity. American Journal of Tropical Medicine and Hygiene, 13, 237-239.
19. Minzi OM, Gupta A, Haule AF, Kagashe GA, Massele AY & Gustafsson LL (2007) Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered. European Journal of Clinical Pharmacology, 63, 457-462.
20. Mutabingwa TK (2005) Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!. Acta Tropica, 95, 305-315.
21. Nebie I, Diarra A, Ouedraogo A et al. (2008) Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infection and Immunity, 76, 759-766.
22. Saute F, Aponte J, Almeda J et al. (2003) Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhica district. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 655-660.
23. Schellenberg D, Menendez C, Aponte JJ et al. (2005) Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2years of a randomised, placebo-controlled trial. Lancet, 365, 1481-1483.
24. Sirima SB, Cotte AH, Konate A et al. (2006) Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. American Journal of Tropical Medicine and Hygiene, 75, 205-211.
25. Van Eijk AM, Ayisi JG, Ter Kuile FO et al. (2004) Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Tropical Medicine and International Health, 9, 351-360.
26. Von Seidlein L & Greenwood BM (2003) Mass administrations of antimalarial drugs. Trends in Parasitology 19, 452-460.
27. Von Seidlein L, Clarke S, Alexander N et al. (2002) Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa. Bulletin of the World Health Organization, 80, 790-796.
28. Von Seidlein L, Walraven G, Milligan PJ et al. (2003) The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 217-225.
29. White NJ, Van Vugt M & Ezzet F (1999) Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clinical Pharmacokinetics, 37, 105-125.